CoChat

Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin

Korth‐Bradley, Joan M., Parks, Virginia, Patat, Alain, Matschke, Kyle, Mayer, Philip, Fleckenstein, Lawrence · 2012 · Clinical Pharmacology in Drug Development
Cited by 41

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The antiparasitic agent moxidectin is under development for the treatment of onchocerciasis. As the first‐in‐human study of moxidectin used a liquid formulation but other trials used tablets, a study was performed to determine the relative bioavailability of the 2 formulations and to gain more information about the pharmacokinetics of moxidectin. Fifty‐eight healthy male participants were randomized to receive open‐label moxidectin (10 mg) as a tablet (n = 29) or liquid (n = 29) formulation. The mean ± SD pharmacokinetic parameters observed following administration of the tablet were peak concentration (C max) 67.1 ± 27.4 ng/mL, time to peak concentration (t max) 3.2 ± 1.4 hours, area under the concentration time curve (AUC) 4403 ± 2360 ng·h/mL, apparent volume of distribution 3635 ± 1720 L, oral clearance 2.83 ± 1.25 L/h, and elimination half‐life 1032 ± 502 hours. The C max and AUC observed following administration of the liquid formulation were 28.6% and 28.8% higher, respectively, and t max 0.9 hours shorter compared with tablets. No serious adverse events (AEs) were observed. The most commonly reported AEs were headache, infection, diarrhea, asthenia, myalgia, and dizziness during the inpatient phase and flu syndrome, headache, and infection during the 6‐month outpatient phase. There was no difference in reporting of these AEs between formulations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2160763x11432508

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 41

Metadata

Authors
Korth‐Bradley, J. M., Parks, V., Patat, A., Matschke, K., Mayer, P., & Fleckenstein, L.
Venue
Clinical Pharmacology in Drug Development
Publisher
Wiley
Published
2012-01
Volume
1
Issue
1
Pages
32-37
ISSN
  • 2160-763X (ISSN-L)
  • 2160-7648
OpenAlex
W2050587086
Cited by
41
References
1
FWCI
1.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin. https://app.cochat.ai/papers/10.1177/2160763x11432508
The paper
Korth‐Bradley, J. M., Parks, V., Patat, A., Matschke, K., Mayer, P., & Fleckenstein, L. (2012). Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin. Clinical Pharmacology in Drug Development. https://doi.org/10.1177/2160763x11432508

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.